دورية أكاديمية
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1–Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial
| العنوان: | Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1–Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial |
|---|---|
| المؤلفون: | Garon, Edward B., Spira, Alexander I., Goldberg, Sarah B., Chaft, Jamie E., Papadimitrakopoulou, Vassiliki, Cascone, Tina, Antonia, Scott J., Brahmer, Julie R., Camidge, D. Ross, Powderly, John D., Wozniak, Antoinette J., Felip, Enriqueta, Wu, Song, Ascierto, Maria L., Elgeioushi, Nairouz, Awad, Mark M. |
| المساهمون: | AstraZeneca |
| المصدر: | Journal of Thoracic Oncology ; volume 18, issue 8, page 1094-1102 ; ISSN 1556-0864 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Pulmonary and Respiratory Medicine, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.jtho.2023.04.020 |
| الإتاحة: | https://doi.org/10.1016/j.jtho.2023.04.020Test https://api.elsevier.com/content/article/PII:S1556086423005245?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S1556086423005245?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.4AD415C1 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.jtho.2023.04.020 |
|---|